FY2025 · ended Dec 31, 2025 · Revenue $38.52M, -5.8% YoY · Filed Mar 27, 2026
Utah Medical Products, Inc. (UTMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $38.5 million and net income of $11.3 million. Free cash flow was $14.3 million. As of Jun 30, 2026 it held $87.5 million in cash and investments and $195,000 in total debt.
Revenue (TTM)
$36.11M
-7.0% vs year-ago TTM
Net income (TTM)
$10.49M
-16.5% vs year-ago TTM
Operating cash flow (TTM)
$11.85M
-16.2% vs year-ago TTM
Free cash flow (TTM)
$11.45M
-17.0% vs year-ago TTM
EPS (TTM)
$3.28
-12.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
3.19M
-2.9% vs prior year
Net cash
$87.33M
as of Jun 30, 2026
Operating margin
28.4%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- UTMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- UT
- Headquarters
- Midvale, UT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 706698
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $38.5M | $40.9M | $50.2M | $52.3M | $49.1M |
| Operating income | $11.4M | $13.6M | $16.8M | $19.8M | $18.9M |
| Net income | $11.3M | $13.9M | $16.6M | $16.5M | $14.8M |
| Diluted EPS | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 |
| Operating cash flow | $14.7M | $14.8M | $22.3M | $21.1M | $21.2M |
| Free cash flow | $14.3M | $14.6M | $21.6M | $20.3M | $20.7M |
| Total assets | $122.5M | $122.5M | $135.5M | $123.9M | $115.6M |
| Total liabilities | $3.3M | $5.1M | $7.1M | $9.6M | $8.5M |
| Stockholders' equity | $119.3M | $117.4M | $128.3M | $114.3M | $107.1M |
| Cash and investments | $85.8M | $83.0M | $92.9M | $75.1M | $61.0M |
| Total debt | $286,000 | $338,000 | $342,000 | $395,000 | $449,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2026 | Aug 31, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2026 | Jul 23, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
All 848 Utah Medical Products, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.